
Shanghai Huiying Medical Technology
A multinational enterprise focusing on the research, development, production and global sales of tumor radiotherapy medical device technology.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | CNY100m | Series B | |
Total Funding | 000k |
BEBIG Medical Group specializes in providing innovative brachytherapy solutions for cancer treatment. Operating in the medical technology sector, the company serves healthcare providers and hospitals globally. BEBIG Medical Group's core product offerings include high-dose-rate (HDR) brachytherapy systems, which are used to deliver precise radiation therapy to cancer patients. The company generates revenue through the sale of its medical devices and related services, including maintenance and support. By focusing on advanced technology and patient outcomes, BEBIG Medical Group aims to improve the effectiveness and efficiency of cancer treatments.
Keywords: brachytherapy, cancer treatment, HDR systems, medical technology, healthcare providers, radiation therapy, patient outcomes, medical devices, global market, advanced technology.